Colonic drug delivery formulation
AssigneeTillotts Pharma AG
InventorsFelipe Varum, Roberto Carlos Bravo González
Life of this patent
Estimating the term…
Loading patent…
AssigneeTillotts Pharma AG
InventorsFelipe Varum, Roberto Carlos Bravo González
Estimating the term…
A delayed release drug formulation contains a core containing a drug and a delayed release coating for intestinal release, where release of the drug in the colon is not hindered by the absence of an alkaline middle layer between the core and the outer layer. The delayed release coating contains an outer coating, and optionally, an isolation layer. The outer coating contains a mixture of an enzymatically degradable polysaccharide which is degradable by colonic enzymes selected from the group of starch, amylose, amylopectin, chitosan, chondroitin sulfate, cyclodextrin, dextran, ptallulan, carrageenan, scleroglucan, curdulan, and levan and a film-forming enteric polymer having a pH threshold at about pH 6 or above. The enzymatically degradable polysaccharide and the enteric polymer are present in the outer coating in a ratio of more than 60:40.
A delayed release drug formulation for oral administration to deliver a drug to the colon of a subject, said formulation comprising:
Dependencies are inferred from the claim text.